Learn about conventional, complementary, and integrative therapies.
Dealing with treatment side effects? Learn about evidence-based therapies to alleviate your symptoms.
Click the orange button to the right to learn more.
Rapid COJEC for high-risk pediatric neuroblastoma can kill the cancer but can also cause short, long-term and late stage side effects. Consider Complementary and Integrative therapies to reduce this risk- Hi
Continue reading“Our study suggests that EPA and DHA (fish oil) induce selective cytotoxic effects in Multiple Myeloma and increase sensitivity to bortezomib” I was diagnosed with multiple myeloma (MM) in
Continue reading“An experimental immune-based therapy more than doubled median survival of patients diagnosed with the most aggressive malignant brain cancer Brain cancer (BC) can be difficult to treat if the patient
Continue reading“Our results confirm that vitamin D deficiency is associated with a substantially increased risk of all-cause dementia and Alzheimer’s disease.” When I read the studies linked and excerpted
Continue readingThe agent (CG0070) yielded an overall 12-month complete response (CR) rate of 30% in a phase 2 single-arm trial in patients with BCG-unresponsive, high-grade Ta, T1, or CIS ± Ta/T1 non-muscle-invasive
Continue readingDespite advances in novel antimyeloma agents,1–4 the use of a salvage autologous stem-cell transplantation (sASCT) has continued to represent an option in well-selected patients with multiple myeloma
Continue readingHi David – My husband was just diagnosed with Stage IV Esophageal Cancer and had been taking diabetes meds prior to diagnosis. He is starting on FOLFOX Monday. I came across the journal studies
Continue readingI am a long-term survivor of a blood cancer called multiple myeloma. I am also a man nearing 60. I have two friends who have had prostatectomies (prostate removal). I have several other friends who have
Continue reading“I often ask myself what I would do if my cancer, multiple myeloma, relapsed. Would I undergo another alternative therapy? Hi David! Good Morning. I have a few questions for you if you don’t
Continue reading“Non-IgM MGUS is considered a preneoplastic condition with an annual risk of progression of approximately 1%. Risk of progression is increased when M protein greater than or equal to 15 g/L and with
Continue reading“Significantly higher overall response rates (MM) and longer duration of remissions were observed in the OE-group (Wobenzym)” Newly diagnosed multiple myeloma patients are often told that their
Continue reading“Overall, these findings suggested that ginsenoside Rg3 induced apoptosis in multiple myeloma cells, at least partially, through upregulation of the expression of Bax.” The list of evidence-based,
Continue reading